Tranylcypromine Sulfate Tablet
Brand names: Tranylcypromine Sulfate
Category: Psychiatry
FDA status: To Be Discontinued · Last FDA update: Oct 21, 2025 · First posted: Oct 21, 2025 · 1 manufacturers, 1 listed presentations
As of Oct 21, 2025, the FDA lists Tranylcypromine Sulfate Tablet as being discontinued. Of 1 manufacturer presentations, 1 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Parnate, Tablet, 10 mg (NDC 0591-5590-01) NDC 0591-5590-01 |
Teva Pharmaceuticals USA, Inc. | Not specified | Supply is expected to be depleted by 12/31/2025. |
Related medications in shortage
Other Psychiatry medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Tranylcypromine Sulfate Tablet (FDA data as of Oct 21, 2025). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Tranylcypromine Sulfate Tablet. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/tranylcypromine-sulfate-tablet.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).